Zhejiang Jolly PharmaceuticalLTD Dividend
Dividend criteriumcontroles 4/6
Zhejiang Jolly PharmaceuticalLTD is a dividend paying company with a current yield of 2.83% that is well covered by earnings.
Belangrijke informatie
2.8%
Dividendrendement
-8.2%
Terugkoop Rendement
Totaal aandeelhoudersrendement | -5.4% |
Toekomstig dividendrendement | 6.5% |
Dividendgroei | 12.3% |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | CN¥0.450 |
Uitbetalingsratio | 60% |
Recente dividendupdates
Recent updates
Investors Still Aren't Entirely Convinced By Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Earnings Despite 32% Price Jump
Oct 17These 4 Measures Indicate That Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Is Using Debt Safely
Oct 06It's A Story Of Risk Vs Reward With Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)
Aug 30We Ran A Stock Scan For Earnings Growth And Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Passed With Ease
Jul 29Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181) Held Back By Insufficient Growth Even After Shares Climb 28%
May 13A Look At The Fair Value Of Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)
May 08There's No Escaping Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Muted Earnings
Mar 01Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: 300181's dividend payments have been volatile in the past 10 years.
Groeiend dividend: 300181's dividend payments have increased over the past 10 years.
Dividendrendement versus markt
Zhejiang Jolly PharmaceuticalLTD Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (300181) | 2.8% |
Markt onderkant 25% (CN) | 0.6% |
Markt Top 25% (CN) | 2.2% |
Gemiddelde industrie (Pharmaceuticals) | 1.7% |
Analist prognose (300181) (tot 3 jaar) | 6.5% |
Opmerkelijk dividend: 300181's dividend (2.83%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Hoog dividend: 300181's dividend (2.83%) is in the top 25% of dividend payers in the CN market (2.22%)
Winstuitkering aan aandeelhouders
Verdiendekking: With its reasonable payout ratio (60.5%), 300181's dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: With its high cash payout ratio (265.5%), 300181's dividend payments are not well covered by cash flows.